Matters of legal in nature including licensing, intellectual property, and lawsuits.
Chalfont St Giles, UK – 23 August 2016 – In a further step to build its portfolio for the rapidly-growing cell therapy industry, GE Healthcare today announced an agreement with STEMCELL Technologies Inc. of Vancouver, Canada to provide T-Cell reagents for commercial-scale cell therapy production. Under the agreement, GE Healthcare will commercialize cGMP-grade versions of... Read more
Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma Kusatsu/Shiga, Japan — June 21, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Kite Pharma, Inc. (“Kite”), United States, under which Takara Bio grants Kite a commercial license to use applicable patents relating... Read more
Monroe, NC- June 15, 2016 Greiner Bio-One North America, Inc. is proud to announce the release of a new line of small laboratory equipment products which includes a Vortex Mixer, Mini Block Heater, Mini Centrifuge, Microplate Centrifuge, Mini Vortex Mixer, and Sapphire Maxipette. These products are used worldwide in medical and research laboratories and Greiner... Read more
CHALFONT ST. GILES, UK and KINGSTON, ONTARIO, CANADA – 8 June 2016 – PnuVax Incorporated (PnuVax), a vaccine and biopharmaceutical company, and GE Healthcare’s Life Sciences business (NYSE: GE) announced today that they have entered an agreement under which PnuVax can acquire GE Healthcare’s intellectual property (IP) relating to an inactivated yellow fever vaccine. Under... Read more
2016 2016/03/22 Takara Bio grants Cellectis SA a commercial license to use RetroNectin® Kusatsu/Shiga, Japan – March 22, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Cellectis SA. Under the agreement, Takara Bio grants Cellectis a commercial license to use RetroNectin® and Takara Bio also supplies RetroNectin® to Cellectis . ... Read more
WAUWATOSA, Wis., Dec. 7, 2015 – The National Basketball Association (NBA) and GE Healthcare (NYSE: GE) today conducted a successful meeting at GE’s Wisconsin offices to discuss the progress of their research collaboration. The partnership, which commenced in July, promotes sports medicine research to benefit not only NBA players but athletes of all levels. Today’s... Read more
We describe a new extinct lineage Manipulatoridae (new family) of cockroaches from the Upper Cretaceous (Cenomanian) amber of Myanmar. Manipulator modificaputis gen. et sp. n. is a morphologically unique extinct cockroach that represents the first (of a total of 29 known worldwide) cockroach family reported exclusively from the Myanmar amber. Read more
MENLO PARK, Calif. and BILLERICA, Mass., May 5, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, and RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of complex genetic diseases, today announced their entry into a co-development and co-marketing agreement to commercialize... Read more
MENLO PARK, Calif., April 27, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced the introduction of several new solutions for targeted sequencing applications.The company has introduced a new workflow that combines Roche NimbleGen’s SeqCap EZ enrichment technology with large DNA fragments (up to... Read more
Thank you for visiting www.mt.com. We have tried to optimize your experience while on the site, but we noticed that you are using an older version of a web browser. We would like to let you know that some features on the site may not be available or may not work as nicely as they... Read more